Main Menu

News and features 

Read the latest stories about our world-leading research, science, fundraising and philanthropy. 

To find out more, you can contact our media team, follow us on social media or visit our press release archive.


Sign up for our newsletters


News

New drug target discovered for aggressive form of prostate cancer 17
Sep
2024

Scientists have discovered that a protein linked to prostate cancer is associated with more aggressive disease – it could be a new target for treatment and used to help predict who will become resistant to hormone therapy. Find out more

Routine MRI scans detect cancers in asymptomatic patients with rare genetic condition 16
Sep
2024

A study has found that people with Li-Fraumeni syndrome would benefit from yearly whole-body MRI scans to screen for cancers Find out more

Improved breast cancer risk tools on the horizon as major study reaches 20-year halfway point 16
Sep
2024

Scientists are developing breast cancer risk tools that will help to identify women at high risk, even if they do not have a family history of the disease, thanks to one of the world’s largest and longest-running studies into the causes of breast cancer. Find out more

See all news articles

Features

Scientific achievements of 2023 05
Dec
2023

We've selected a range of discoveries from the academic year that highlight the quality and breadth of our basic, translational and clinical research. Find out more

Untapping the full potential of immunotherapies for more people with cancer 06
Jun
2023

Immunotherapy works by sparking the body’s own immune system into action against tumours. It has become a first-choice treatment for some types of cancer, and now there are exciting opportunities to unlock its benefits for more patients through research. Jane Shepley explores the story behind immunotherapy and how we can untap its potential. Find out more

Over a decade of abiraterone: the drug that revolutionised advanced prostate cancer care 14
Mar
2023

This Prostate Cancer Awareness Month, we’re celebrating over 10 years since abiraterone was first recommended by NICE in England as a treatment for advanced prostate cancer. We share the story of the drug’s discovery, how a landmark trial changed the way advanced prostate cancer is treated today, and what the drug has meant for patients who are currently treated with it. Find out more

See all feature articles